Literature DB >> 23843591

Associations of fibroblast growth factor 23 with parameters of phosphate metabolism in incident peritoneal dialysis patients.

Edyta Golembiewska1, Krzysztof Safranow, Joanna Kabat-Koperska, Kazimierz Ciechanowski, Joanna Bober, Anna Bogacka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23843591      PMCID： PMC3707725          DOI： 10.3747/pdi.2012.00116

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN： 0896-8608            Impact factor:   1.756


× No keyword cloud information.
  15 in total

1.  FGF23 induces left ventricular hypertrophy.

Authors:  Christian Faul; Ansel P Amaral; Behzad Oskouei; Ming-Chang Hu; Alexis Sloan; Tamara Isakova; Orlando M Gutiérrez; Robier Aguillon-Prada; Joy Lincoln; Joshua M Hare; Peter Mundel; Azorides Morales; Julia Scialla; Michael Fischer; Elsayed Z Soliman; Jing Chen; Alan S Go; Sylvia E Rosas; Lisa Nessel; Raymond R Townsend; Harold I Feldman; Martin St John Sutton; Akinlolu Ojo; Crystal Gadegbeku; Giovana Seno Di Marco; Stefan Reuter; Dominik Kentrup; Klaus Tiemann; Marcus Brand; Joseph A Hill; Orson W Moe; Makoto Kuro-O; John W Kusek; Martin G Keane; Myles Wolf
Journal:  J Clin Invest       Date:  2011-10-10       Impact factor: 14.808

Review 2.  An overview of the pathophysiology of vascular calcification in chronic kidney disease.

Authors:  Tomasz Stompór
Journal:  Perit Dial Int       Date:  2007-06       Impact factor: 1.756

3.  Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship?

Authors:  Hannes Olauson; Abdul Rashid Qureshi; Tetsu Miyamoto; Peter Barany; Olof Heimburger; Bengt Lindholm; Peter Stenvinkel; Tobias E Larsson
Journal:  Nephrol Dial Transplant       Date:  2010-04-05       Impact factor: 5.992

4.  Elevated FGF 23 and phosphorus are associated with coronary calcification in hemodialysis patients.

Authors:  Poyyapakkam R Srivaths; Stuart L Goldstein; Douglas M Silverstein; Rajesh Krishnamurthy; Eileen D Brewer
Journal:  Pediatr Nephrol       Date:  2011-02-27       Impact factor: 3.714

5.  Peritoneal membrane phosphate transport status: a cornerstone in phosphate handling in peritoneal dialysis.

Authors:  Ana Paula Bernardo; Sebastián Azorin Contesse; Maria Auxiliadora Bajo; Anabela Rodrigues; Gloria Del Peso; Marta Ossorio; António Cabrita; Rafael Selgas
Journal:  Clin J Am Soc Nephrol       Date:  2010-11-29       Impact factor: 8.237

6.  Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.

Authors:  Tamara Isakova; Patricia Wahl; Gabriela S Vargas; Orlando M Gutiérrez; Julia Scialla; Huiliang Xie; Dina Appleby; Lisa Nessel; Keith Bellovich; Jing Chen; Lee Hamm; Crystal Gadegbeku; Edward Horwitz; Raymond R Townsend; Cheryl A M Anderson; James P Lash; Chi-Yuan Hsu; Mary B Leonard; Myles Wolf
Journal:  Kidney Int       Date:  2011-03-09       Impact factor: 10.612

7.  Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients.

Authors:  Heng Jung Hsu; Mai-Szu Wu
Journal:  Am J Med Sci       Date:  2009-02       Impact factor: 2.378

8.  High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.

Authors:  Guillaume Jean; Jean-Claude Terrat; Thierry Vanel; Jean-Marc Hurot; Christie Lorriaux; Brice Mayor; Charles Chazot
Journal:  Nephrol Dial Transplant       Date:  2009-04-25       Impact factor: 5.992

9.  Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.

Authors:  Orlando M Gutiérrez; Michael Mannstadt; Tamara Isakova; Jose Alejandro Rauh-Hain; Hector Tamez; Anand Shah; Kelsey Smith; Hang Lee; Ravi Thadhani; Harald Jüppner; Myles Wolf
Journal:  N Engl J Med       Date:  2008-08-07       Impact factor: 91.245

10.  Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  Francesca Tentori; Margaret J Blayney; Justin M Albert; Brenda W Gillespie; Peter G Kerr; Jürgen Bommer; Eric W Young; Tadao Akizawa; Takashi Akiba; Ronald L Pisoni; Bruce M Robinson; Friedrich K Port
Journal:  Am J Kidney Dis       Date:  2008-06-02       Impact factor: 8.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.